Cargando…
伴ASXL1基因突变初诊急性髓系白血病患者的临床特征及生存分析
OBJECTIVE: To examine the survival rates and clinical characteristics of people with newly discovered non-M(3) acute myeloid leukemia(AML)who carry the ASXL1 gene mutation. METHODS: From January 2016 to April 2021, the clinical information of patients with newly diagnosed non-M(3) AML at Shandong Un...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669635/ https://www.ncbi.nlm.nih.gov/pubmed/36709197 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.10.006 |
Ejemplares similares
-
TP53基因突变阳性成人急性髓系白血病患者初诊临床及分子遗传学特征分析
Publicado: (2019) -
初诊急性髓系白血病合并骨髓纤维化患者的临床特征、基因突变及预后分析
Publicado: (2020) -
伴AML1-ETO融合基因的急性髓系白血病患者ASXL2基因突变及临床特征分析
Publicado: (2016) -
基于二代测序分析伴RAS突变初诊正常核型急性髓系白血病患者的临床特征及预后
Publicado: (2023) -
一个伴CEBPA基因突变的急性髓系白血病家系调查及临床分析
Publicado: (2020)